These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 37731994)

  • 21. How to manage splanchnic vein thrombosis in patients with liver disease.
    Riva N; Ageno W
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):281-288. PubMed ID: 38066910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis.
    Magaz M; Alvarez-Larrán A; Colomer D; López-Guerra M; García-Criado MÁ; Mezzano G; Belmonte E; Olivas P; Soy G; Cervantes F; Darnell A; Ferrusquía-Acosta J; Baiges A; Turon F; Hernández-Gea V; García-Pagán JC
    J Hepatol; 2021 Jan; 74(1):89-95. PubMed ID: 32679300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival after splanchnic vein thrombosis: A 20-year nationwide cohort study.
    Søgaard KK; Darvalics B; Horváth-Puhó E; Sørensen HT
    Thromb Res; 2016 May; 141():1-7. PubMed ID: 26945454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Factors, Diagnosis, Management, and Outcome of Splanchnic Vein Thrombosis: A Retrospective Analysis.
    Derman BA; Kwaan HC
    Semin Thromb Hemost; 2015 Jul; 41(5):503-13. PubMed ID: 26080303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Portal Vein Thrombosis in Cirrhosis.
    Shukla A; Giri S
    J Clin Exp Hepatol; 2022; 12(3):965-979. PubMed ID: 35677518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of prothrombotic factors in patients with Budd-Chiari syndrome or non-cirrhotic nonmalignant portal vein thrombosis: A hospital-based observational study.
    Fan J; Wang Q; Luo B; Chen H; Wang Z; Niu J; Yuan J; Yuan X; Bai W; He C; Guo W; Li K; Yin Z; Fan D; Han G
    J Gastroenterol Hepatol; 2020 Jul; 35(7):1215-1222. PubMed ID: 31711259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Splanchnic vein thrombosis: clinical presentation, risk factors and treatment.
    De Stefano V; Martinelli I
    Intern Emerg Med; 2010 Dec; 5(6):487-94. PubMed ID: 20532730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies.
    Calcaterra I; Tufano A; Strano F; Rufolo P; Donnarumma S; Palermo V; De Ruberto F; Cimino E; Guerrino C; Conca P; Iannuzzo G; Di Minno M
    J Thromb Haemost; 2024 Feb; 22(2):534-544. PubMed ID: 37926192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Splanchnic vein thrombosis].
    Gouin B; Robert-Ebadi H; Casini A; Beauverd Y; Fontana P; Righini M; Elkrief L
    Rev Med Suisse; 2017 Dec; 13(586):2138-2143. PubMed ID: 29211374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-associated splanchnic vein thrombosis: Clinical features upon diagnosis and short-term outcomes.
    García-Villa A; Criado-Álvarez JJ; Carnevali M; Aramberri M; Font C; Díaz-Pedroche C
    Thromb Res; 2023 Nov; 231():84-90. PubMed ID: 37832365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abdominal thromboses of splanchnic, renal and ovarian veins.
    De Stefano V; Martinelli I
    Best Pract Res Clin Haematol; 2012 Sep; 25(3):253-64. PubMed ID: 22959542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Splanchnic vein thrombosis: Clinical manifestations, risk factors, management, and outcomes.
    Kawata E; Siew DA; Payne JG; Louzada M; Kovacs MJ; Lazo-Langner A
    Thromb Res; 2021 Jun; 202():90-95. PubMed ID: 33798804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usage of Direct Acting Oral Anticoagulants in Cirrhotic and Non-Cirrhotic Portal Vein Thrombosis: A Systematic Review.
    Gupta S; Hidalgo J; Singh B; Iyer A; Yang Y; Short A; Singh S; Bhatt H; Gupta S
    Cureus; 2021 Aug; 13(8):e16922. PubMed ID: 34367844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis.
    Wang X; Ma Y; Hui X; Li M; Li J; Tian J; Wang Q; Yan P; Li J; Xie P; Yang K; Yao L
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD010956. PubMed ID: 37058421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulation in splanchnic and cerebral vein thrombosis: An international vignette-based survey.
    Riva N; Carrier M; Gatt A; Ageno W
    Res Pract Thromb Haemost; 2020 Oct; 4(7):1192-1202. PubMed ID: 33134784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical approach to splanchnic vein thrombosis: risk factors and treatment.
    Riva N; Donadini MP; Dentali F; Squizzato A; Ageno W
    Thromb Res; 2012 Oct; 130 Suppl 1():S1-3. PubMed ID: 23026649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis.
    Valeriani E; Di Nisio M; Riva N; Cohen O; Porreca E; Senzolo M; De Gottardi A; Magaz M; Garcia-Pagan JC; Ageno W
    Thromb Haemost; 2021 Jul; 121(7):867-876. PubMed ID: 33525037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis: similarities and differences.
    Smalberg JH; Kruip MJ; Janssen HL; Rijken DC; Leebeek FW; de Maat MP
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):485-93. PubMed ID: 21325670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Splanchnic vein thrombosis in acute pancreatitis: a review of treatment indications, methods, and outcomes in a single institution.
    Wilson TM; Daneshmand A; Parys S; Watanabe Y
    ANZ J Surg; 2023 Oct; 93(10):2487-2491. PubMed ID: 36994906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Splanchnic Vein Thrombosis.
    Valla D
    Semin Thromb Hemost; 2015 Jul; 41(5):494-502. PubMed ID: 26080307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.